As the Ebola death toll climbs above 2,000, a university researcher is working to develop a vaccine for the virus.
Alan L. Schmaljohn, a microbiology and immunology professor at University of Maryland, Baltimore, has successfully isolated one of the structural sections of the virus, which can be used as a platform for a working vaccine.